A disconnect exists in the industry between GPs who view continuation funds as a desirable way to hold certain assets beyond the limits of a traditional private equity fund, and LPs who generally would prefer a regular exit.
4 min read · 28 September 2023
Nico Taverna, founding partner at the GP-led focused firm, talks to Secondaries Investor about how it will invest its €350m second fund.
5 min read · 28 September 2023
Three buyers co-led the novel transaction involving insurance asset Markerstudy, which was separately involved in an M&A process.
3 min read · 26 September 2023
Sources point to an influx of deals hitting the market toward the end of summer that may drive volume, especially as pricing has improved.
2 min read · 20 September 2023
A footnote in the US Securities and Exchange Commission’s new rules suggests continuation funds structured as cross fund trades won’t be subject to third-party fairness opinion and valuation letters.
3 min read · 31 August 2023
Single-asset deals priced at more than 9 percentage points higher than their multi-asset counterparts in the first half of this year.
2 min read · 30 August 2023
GP-led deals, which once dominated volume, have taken a back seat to LP portfolio sales, which represented the majority of transactions in the first half of the year.
2 min read · 31 July 2023
The transaction is the second the UK-headquartered buyout firm has closed this year after its single-asset process involving SERB.
2 min read · 13 July 2023
Healthcare-related assets make up a significant chunk of potential dealflow in the GP-led secondaries market given the sector’s characteristics and outlook.
4 min read · 13 July 2023
